TSXV:TRL.H - Post by User
Comment by
dmacdon Mar 04, 2019 7:43pm
93 Views
Post# 29441134
RE:Avanafil NDS
RE:Avanafil NDS What would it take to get an investor presentation on the web so we can figure out what the pipeline could generate in sales or royalties??? Cashflow vs debt repayments are not well enough understood to dip in here. Surprisingly low valuation for approved drugs which infers other risks. We think Nestesto will do well but have no idea on the royalty structure or earning potential. Management must not care about shareholders or want them in the dark. Hmmm.